|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT04146259 |
|
Date of registration:
|
29/10/2019 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism
|
|
Scientific title:
|
Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism |
|
Date of first enrolment:
|
January 1, 2017 |
|
Target sample size:
|
109 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT04146259 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Greece
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Indication for total thyroidectomy
Exclusion Criteria:
- parathyroid disorders, chronic kidney disease (eGFR< 60 ml/min), treatment with
antiosteoporosis drugs, rheumatic disease and history of long term (>1 month) or
current corticosteroid use
Age minimum:
19 Years
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypoparathyroidism Postprocedural
|
|
Intervention(s)
|
|
Drug: calcium carbonate and alphacalcidol
|
|
Primary Outcome(s)
|
|
change in circulating serum sclerostin levels (pmol/L) during the observation period
[Time Frame: 7 days]
|
|
Secondary Outcome(s)
|
|
the between groups difference in % changes of circulating sclerostin
[Time Frame: 7 days]
|
|
Secondary ID(s)
|
|
1387/08-12-2015
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|